Diversified Metals and Mining

US Antimony

US Antimony released FY2026 Q1 earnings on May 14, 2026, After-Market EST: Actual Revenue USD 6.784 M (Forecast USD 14.83 M), Actual EPS USD -0.0799 (Forecast USD -0.02)

Antimony Corp. Reaffirms 2026 Full-Year Revenue Guidance at $125 Million

US Antimony to Release FY2026 Q1 Earnings on May 14 After-Market EST, Forecast Revenue USD 14.83 M, EPS USD -0.0033

American Antimony Company and Western Frontier Partner on New Mine Planning Phase at King of Antimony Mine

UAMY Confirms Ontario's Fostung Project as Tungsten-bearing Metasedimentary Deposit

American Bismuth Schedules 2026 Annual General Meeting

US Antimony night session stock price up 7.63%

UAMY Discusses $248 Million DLA Contract and Plans to Expand Bismuth Production

UAMY Stock Opens Lower, Analysts Maintain Buy Rating

US Antimony released FY2025 Q4 earnings on March 19 After-Market EST, actual revenue USD 13.03 M (forecast USD 12.77 M), actual EPS USD -0.01 (forecast USD 0.0066)

US Antimony released FY2025 annual earnings on March 19 After-Market EST, actual revenue USD 39.26 M (forecast USD 39.18 M), actual EPS USD -0.04 (forecast USD -0.025)

US Antimony Doubles Revenue in Fiscal 2025 with Expanded Net Loss

US Antimony to Release FY2025 Annual Earnings on March 19 After-Market (EST), Forecast Revenue USD 39.18 M, EPS USD -0.025

UAMY Receives $27 Million Funding Award from the Department of War

American Antimony Completes Fostung Tungsten Mine Resource Study, Plans Further Exploration

UAMY Announces Strategy to Enhance North American Bismuth Supply Chain

US Bismuth Company Releases Investor Update, Records Record Financial Performance in 2025

Americas Gold and Silver and United States Antimony Establish Antimony Processing Joint Venture

American Antimony Company Secures Exclusive Antimony Flakes Supply Contract from Bolivia

American Antimony Company Acquires a Facility for $4.75 Million in Cash

OPTIMI HEALTH CORP

HCW Biologics

GCL Global

Silexion Therapeutics

Vida Global

BiomX

MetaVia

Micware

MicroAlgo

Quantum Cyber NV

UAMY

US Antimony rose 13.78%; USA Rare Earth rose 11.65%, with a transaction volume of USD 268 million; MP Materials rose 1.67%, with a transaction volume of USD 256 million; Rio Tinto rose 1.93%, with a transaction volume of USD 143 million; BHP rose 1.87%, with a market value of USD 211.8 billion

Price Alert

USA Rare Earth

MP Materials

Rio Tinto

US Antimony rose 13.78% during intraday trading, with clear capital flow, attracting attention due to increased market volatility

GDXJ

PICK

RING

United States Antimony (UAMY) shares recently fell 10% in a day, down 19% for the month but up 19% over three months. Analysts value the stock at $12.67, suggesting it is undervalued compared to its current price of $8.61. The company is expanding processing capacity and increasing ore supply, which may support revenue growth. However, valuation risks exist due to a high P/S ratio of 32.5x. Investors are advised to assess both potential upsides and risks.

Simplywall

VanEck Junior Gold Miners ETF

ISHRS MSCI Glb Slct Met & Mining

SPDR S&P Mtls & Mng

iShares MSCI Global Gold Miners

VanEck Gold Miners ETF

A Look At United States Antimony’s Valuation After A Volatile Share Price Pullback

United States Antimony (UAMY) has surged 244% over the past year, currently priced at $8.61. Despite a year-to-date increase of 45.2%, it has recently fallen 19.2%. Valuation analysis indicates it is overvalued by 38.7% based on a Discounted Cash Flow model, with a fair value of $6.21 per share. The stock's Price-to-Sales ratio of 32.53x significantly exceeds industry averages, suggesting it trades well above typical levels.

Is It Too Late To Consider United States Antimony (UAMY) After Its 244% One-Year Surge?

United States Antimony Corp. reported Q1 earnings with stable sales of $6.8 million, highlighting growth in zeolite demand and a strong cash position of $118.9 million. The company secured a $27 million Department of Defense grant and is expanding capacity at its Thompson Falls facility. Despite a net loss of $11.3 million due to rising costs, management remains optimistic about long-term growth, including a joint venture targeting half of the U.S. antimony market. The stock's uplisting to NYSE has boosted its market capitalization significantly.

Tip Ranks

Americas Gold and Silver

United States Antimony Maps Ambitious Growth Path

Earnings Watch

US Antimony | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 6.8 M

Jake Sekelsky from Alliance Global Partners has reiterated a Buy rating on United States Antimony (UAMY) with a price target of $13.50. The analyst, known for a 34.2% average return and a 53.71% success rate, indicates a Strong Buy consensus for UAMY, with an average price target of $12.67.

Avino Silver & Gold Mines

Endeavour Silver

United States Antimony (UAMY) Receives a Buy from Alliance Global Partners

United States Antimony reported a Q1 loss of $0.08 per diluted share, compared to breakeven a year ago. Revenue fell to $6.8 million from $7.0 million, missing analyst expectations of $14.8 million. The company maintained its 2026 gross revenue guidance at $125 million. Shares dropped about 3% in after-hours trading.

fidelity

United States Antimony Reports Q1 Loss, Revenue Falls

US Antimony | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 6.784 M

US Antimony(UAMY.US)